Brief: Genfit Says All Other Clinical Trials Have Been Paused Or Postponed Due To Pandemic

Genfit SA

08/04/2020 22:06

April 8 (Reuters) - Genfit SA  GNFT.PA :
    * GENFIT REPORTS FULL-YEAR 2019 FINANCIAL RESULTS AND
CORPORATE
UPDATE
    * GENFIT SA - TOPLINE INTERIM RESULTS FROM PHASE 3 CLINICAL
TRIAL
RESOLVE-IT EXPECTED BY END OF MAY 2020
    * GENFIT SA - CASH POSITION OF EUR 277MM AS OF DECEMBER 31,
2019
    * GENFIT SA - ALL OTHER CLINICAL TRIALS HAVE BEEN PAUSED OR
POSTPONED DUE TO COVID-19 PANDEMIC
    * GENFIT SA - NIS4 DEVELOPMENT WILL CONTINUE, AIMING FOR FDA
SUBMISSION OF IVD (IN VITRO DIAGNOSTIC) IN 1H21
    * GENFIT SA - EXPENDITURES IN 2020 WILL STRONGLY DEPEND ON
NATURE
OF TOPLINE RESULTS FROM RESOLVE-IT PHASE 3 CLINICAL TRIAL

Source text for Eikon:  ID:nGNX5KB76w 
Further company coverage:  GNFT.PA 

 ((Reuters.Briefs@thomsonreuters.com;))